We are live on
!
Find out more
JAIC
Josh Arnold Investment Consultant Portfolio holdings
AUM
$117M
1-Year Est. Return
26.5%
This Fund
S&P 500
This Quarter
Est. Return
+20.28%
1 Year Est. Return
+26.5%
3 Year Est. Return
+120.94%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$103M
AUM Growth
+$18.5M
(+22%)
Cap. Flow
+$2.14M
Cap. Flow
% of AUM
2.08%
Top 10 Holdings %
Top 10 Hldgs %
95.62%
Holding
35
New
19
Increased
4
Reduced
7
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pagaya Technologies
PGY
|
+$1.79M |
| 2 |
DraftKings
DKNG
|
+$1.5M |
| 3 |
EDR
Endeavor Group Holdings, Inc.
EDR
|
+$810K |
| 4 |
CLBTW
Cellebrite DI Ltd. Warrants
CLBTW
|
+$775K |
| 5 |
NVIDIA
NVDA
|
+$647K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.88M |
| 2 |
PENN Entertainment
PENN
|
+$1.37M |
| 3 |
Amazon
AMZN
|
+$1.15M |
| 4 |
Caesars Entertainment
CZR
|
+$914K |
| 5 |
AAMC
Altisource Asset Management Corp
AAMC
|
+$266K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 75.31% |
| 2 | Consumer Discretionary | 18.54% |
| 3 | Financials | 1.5% |
| 4 | Healthcare | 1.35% |
| 5 | Communication Services | 0.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Humacyte
HUMA
$170M
| $109K | 0.11% |
+38,000
| New | +$137K |
|
|
CANO.WS
27
DELISTED
Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
| $76.3K | 0.07% |
+363,132
| New | +$91K |
|
28
A2Z Smart Technologies
AZ
$288M
| $67K | 0.07% |
+10,598
| New | +$45.7K |
|
|
EVLVW
29
DELISTED
Evolv Technologies Warrant
EVLVW
| $51.5K | 0.05% |
+37,620
| New | +$36.4K |
|
30
TH International
THCH
$51.3M
| $44.8K | 0.04% |
+3,120
| New | +$56K |
|
|
VLN.WS
31
DELISTED
Valens Semiconductor Ltd Warrants
VLN.WS
| $17.3K | 0.02% |
+105,917
| New | +$15K |
|
|
32
PENN Entertainment
PENN
$2.58B
| – | – |
-46,175
| Closed | -$1.37M |
|
33
GeneDx Holdings
WGS
$2.44B
| – | – |
-630
| Closed | -$8K |
|
|
AAMC
34
DELISTED
Altisource Asset Management Corp
AAMC
| – | – |
-6,939
| Closed | -$266K |
|
|
CMAX
35
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| – | – |
-2,377
| Closed | -$190K |
|
Similar funds
LHEI
OP
FCM
SI
ECP
FIT
WSA
WLC
Josh Arnold Investment Consultant's Q2 2023 Portfolio in Review
As of Q2 2023, Josh Arnold Investment Consultant held 35 positions worth $103M, up 22% from $84.3M the previous quarter. Its ten largest holdings account for 96% of the portfolio.
Josh Arnold Investment Consultant's Q2 2023 filing shows 19 new, 4 increased, 7 reduced and 4 closed positions. Its largest new stake was Pagaya Technologies: 143,361 shares worth $2.41M. The largest sale was Apple, an estimated $1.88M.
By sector, the portfolio is most concentrated in Technology at 75% of assets, down from 77% a quarter earlier, followed by Consumer Discretionary and Financials.
- Josh Arnold Investment Consultant's largest Q2 2023 buy was Pagaya Technologies: 143,361 shares worth $2.41M.
- Josh Arnold Investment Consultant added most to Starling Oncology, Inc. Common Stock in Q2 2023, an estimated $498K increase.
- Josh Arnold Investment Consultant's biggest Q2 2023 reduction was Apple, cutting an estimated $1.88M.
- Josh Arnold Investment Consultant fully exited PENN Entertainment in Q2 2023, selling an estimated $1.37M.
- Josh Arnold Investment Consultant's ten largest holdings make up 96% of its $103M portfolio in Q2 2023.
- Josh Arnold Investment Consultant opened 19 new positions and closed 4 in Q2 2023.
- Josh Arnold Investment Consultant's portfolio value rose 22% quarter-over-quarter to $103M.
Based on Josh Arnold Investment Consultant's 13F filing for Q2 2023, filed 14 Aug 2023.